首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1471951

生育服務市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按程序、患者類型、最終用戶和地理位置

Fertility Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Procedure, Patient Type, End User, and Geography

出版日期: 2024年03月18日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

依據「2031 年生育服務市場預測 - COVID-19 影響和全球分析 - 按程序、患者類型、最終用戶」的新研究，該市場預計將從 2023 年的 329.9 億美元成長到 67.12 美元到2031 年將達到10 億；預計 2023 年至 2031 年複合年成長率為 9.3%。市場成長歸因於日益成長的社會和環境因素以及婦科疾病盛行率的增加。體外受精（IVF）過程中不斷進步的技術可能為生育服務市場提供成長機會。然而，與生育服務相關的高成本阻礙了高壓氧治療市場的成長。

遺傳性疾病和不孕問題的治療是輔助受孕的生育服務的一部分。胞漿內單一精子注射（ICSI）和體外受精（IVF）等輔助生殖技術（ART）的發展是生育服務市場最重要的發展之一。這些技術使體外受孕胚胎成為可能，增加了健康懷孕的可能性，徹底改變了生殖醫學。其他進步包括植入前基因檢測、胚胎冷凍保存和卵子冷凍，為尋求生育治療的夫婦和個人提供了更多選擇。

2023年，亞太地區在全球生育服務市場中佔據主要佔有率。幾種不孕不育藥物的引入和快速分銷推動了該地區的市場成長。預計不孕症治療領域研究活動的增加將在未來幾年為區域市場帶來新的機會。此外，美國佔據北美市場的最大佔有率。生活方式的改變以及導致男性和女性不孕和婦科疾病的不健康飲食趨勢的增加是市場成長的原因。

體外受精 (IVF) 過程中不斷進步的技術推動了生育服務市場的成長機會

體外受精技術的最新進展正在改變生育治療的格局。從基因篩檢到胚胎延時成像，再到人工智慧和改進的培養基，這些創新為飽受不孕症的夫婦帶來了希望。這些進步代表了改變體外受精領域、提高成功率並改善整體患者體驗的尖端技術和工藝。

進階說明

植入前基因檢測 (PGT) PGT 可以對胚胎進行篩檢，以在植入前識別遺傳異常，透過選擇健康的胚胎來增加成功懷孕的機會。

延時胚胎成像使用延時技術連續監測胚胎發育，可以根據生長模式和里程碑來更好地選擇胚胎，從而提高體外受精的成功率。

人工智慧 (AI) 和機器學習人工智慧和機器學習分析患者資料和胚胎髮育，以提供個人化治療建議，最佳化 IVF 結果。

卵巢組織冷凍保存這項技術可以為接受癌症治療或其他影響生育能力的醫療手術的女性冷凍和保存含有存活卵子的卵巢組織。

改良的培養基先進的培養基配方為實驗室胚胎發育創造了理想的環境，從而提高胚胎品質和體外受精成功率。

卵子冷凍技術玻璃化冷凍是一種快速冷凍方法，提高了卵子冷凍的成功率，為女性保留生育能力提供了更多選擇。

單一胚胎移植 (SET) SET 涉及移植精心挑選的單一胚胎，可降低多胎妊娠的風險，在維持高成功率的同時最大限度地減少併發症。

此外，在生育服務市場營運的大公司正在開發新技術來最佳化體外受精，從而獲得競爭優勢。 2022 年 10 月，美國醫療設備製造商 Alife Health 推出了 Alife Assist 平台，這是一系列旨在利用數據驅動的見解和人工智慧 (AI) 徹底改變 IVF 的產品。該平台有助於支持 IVF 關鍵階段的臨床決策並簡化生育診所運作。這個創新平台由 Stim Assist、Embryo Assist 和 Insights 組成，為生殖內分泌學家、胚胎學家和診所管理人員提供全面支持，以改善胚胎分級、藥物劑量和即時性能監控，最終改善患者體驗和 IVF 成功率。預計這些進步將為未來的市場成長提供機會。

基於過程的見解

根據程序，生育服務市場分為輔助生殖技術、人工授精和生育手術。輔助生殖技術領域在 2023 年佔據最大市場佔有率。輔助生殖技術市場進一步細分為體外受精和胞漿內單一精子注射。

基於患者類型的見解

生育服務市場根據患者類型分為男性和女性。到 2023 年，女性細分市場將佔據更大的市場佔有率。

基於最終用戶的見解

就最終用戶而言，生育服務市場分為生育中心、醫院和外科診所等。生育中心細分市場在 2023 年佔據最大的市場佔有率，預計 2023 年至 2031 年複合年成長率最高。

領先企業正在實施擴張、合作、推出新產品和獲取新客戶群等策略，以挖掘現有的商機。

2022 年 12 月，Care Fertility Group 進入美國和西班牙，擴大了其全球影響力。

2022 年 11 月，麥凱日間專科醫院迎來了新的 Virtus 快速內視鏡診所的開幕。

2022 年 10 月，Indira IVF 與 Maven Clinic 合作，這是一家總部位於美國的公司，在基於遠距醫療的虛擬診所的幫助下，專門從事女性和家庭健康。此次合作旨在為印度的 Maven 成員提供 Indira IVF 的高品質臨床護理、其他福利以及透過 Maven 平台提供的最佳虛擬家庭教育護理。 Indira IVF 是一家總部位於印度的連鎖專科不孕症診所。

2022 年 8 月，Genea Fertility 成為澳洲猶太生育網路 (AJFN) 年度大型募款活動的白金贊助商。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 和全球疾病負擔研究是準備生育服務市場報告時參考的主要和次要來源。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 13 章：生育服務市場 - 主要公司概況

CooperSurgical, Inc
Vitrolife
Cook Medical
Care Fertility
INVO Bioscience
Carolinas Fertility Institute
Genea Limited
Merck KGaA
LABOTECT GmbH
Monash IVF Group Limited

第 14 章：附錄

簡介目錄

Product Code: TIPRE00004739

According to our new research study on "Fertility Services Market Forecast to 2031 - COVID-19 Impact and Global Analysis - by Procedure, Patient Type, End User," the market is anticipated to grow from US$ 32.99 billion in 2023 to US$ 67.12 billion by 2031; it is estimated to register a CAGR of 9.3% during 2023-2031. Market growth is attributed to the growing social and environmental factors and increasing prevalence of gynecological conditions. Growing technological advancements in in-vitro fertilization (IVF) process are likely to provide growth opportunities for the fertility services market. However, high costs associated with fertility services hinder the growth of the hyperbaric oxygen therapy market.

Treatments for genetic disorders and infertility problems are part of fertility services to aid conception. The development of assisted reproductive technologies (ART) such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), is one of the most significant developments in the fertility services market. These techniques have revolutionized reproductive medicine by making conceiving an embryo outside the body possible, thereby increasing the likelihood of a healthy pregnancy. Other advances include pre-implantation genetic testing, embryo cryopreservation, and egg freezing, providing additional options for couples and individuals pursuing fertility treatments.

Asia Pacific accounted for a major share of the global fertility services market in 2023. The Asia Pacific fertility services market is segmented into the China, Japan, India, South Korea, Australia, rest of Asia Pacific. The introduction and rapid distribution of several infertility drugs drive the market growth in this region. Increasing research activities in infertility treatments are predicted to open up new opportunities for the regional market in the coming years. Furthermore, the US held the largest share of the North American market. Changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the market growth.

Growing Technological Advancements in In-Vito Fertilization (IVF) Process Fuels the Fertility Services Market Growth Opportunities

Recent advances in IVF technology are changing the landscape of fertility treatment. From genetic screening to time-lapse imaging of embryos to artificial intelligence and improved culture media, these innovations offer hope for couples struggling with infertility. These advances represent cutting-edge technologies and techniques transforming the field of in vitro fertilization, increasing success rates, and improving the overall patient experience.

AdvancementExplanation

Preimplantation Genetic Testing (PGT)PGT allows for the screening of embryos to identify genetic abnormalities before implantation, increasing the chances of a successful pregnancy by selecting healthy embryos.

Time-lapse Embryo ImagingContinuous monitoring of embryo development using time-lapse technology allows for better embryo selection based on growth patterns and milestones, improving IVF success rates.

Artificial Intelligence (AI) & Machine LearningAI and machine learning analyze patient data and embryonic development to provide personalized treatment recommendations, optimizing IVF outcomes.

Ovarian Tissue CryopreservationThis technology enables the freezing and preservation of ovarian tissue, containing viable eggs, for women undergoing cancer treatment or other medical procedures that affects fertility.

Improved Culture MediaAdvanced culture media formulations create an ideal environment for embryo development in the lab, leading to higher embryo quality and better IVF success rates.

Egg Freezing TechniquesVitrification, a rapid freezing method, has improved egg-freezing success rates, giving women more options for preserving their fertility.

Single Embryo Transfer (SET)Reducing the risk of multiple pregnancies, SET involves transferring a single carefully selected embryo, maintaining high success rates while minimizing complications.

Further, large companies operating in the fertility services market are developing new technologies to optimize IVF and thus gain a competitive advantage. In October 2022, a US-based medical device manufacturer, Alife Health, launched the Alife Assist platform, a range of products designed to revolutionize IVF by leveraging data-driven insights and artificial intelligence (AI). The platform helps in supporting clinical decision-making during key IVF phases and streamline fertility clinic operations. This innovative platform, consisting of Stim Assist, Embryo Assist, and Insights, provides comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators to improve embryo grading, drug dosing, and real-time performance monitoring, ultimately improving patient experience and IVF success rates. Such advancements are expected to provide opportunities for the market growth in future.

Procedure -Based Insights

Based on procedure, the fertility services market is segmented into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment accounted for the largest market share in 2023. It is expected to register the highest CAGR during 2023-2031. The market for the assisted reproductive technology segment is further segmented into in vitro fertilization and intracytoplasmic sperm injection.

Patient Type -Based Insights

The fertility services market, based on patient type, is bifurcated into male and female. The female segment held a larger market share in 2023. However, the male segment is anticipated to register a higher CAGR during the forecast period.

End User -Based Insights

In terms of end user, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is anticipated to register the highest CAGR during 2023-2031.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

In December 2022, Care Fertility Group expanded its global reach by entering into the US and Spain.

In November 2022, Mackay Specialist Day Hospital welcomed the opening of the new Virtus Rapid Access Endoscopy Clinic.

In October 2022, Indira IVF collaborated with Maven Clinic, a US-based company specializing in women's and family health with the help of telemedicine-based virtual clinics. The collaboration aimed to provide Maven members in India access to Indira IVF's high-quality clinical care, other benefits, and the best virtual family education care available through the Maven platform. Indira IVF is an India-based chain of specialty infertility clinics.

In August 2022, Genea Fertility was a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the fertility services market report.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Fertility Services Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Fertility Services Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Fertility Services Market - Global Market Analysis

6.1 Fertility Services - Global Market Overview
6.2 Fertility Services - Global Market and Forecast to 2031

7. Fertility Services Market - Revenue Analysis (USD Million) - By Procedure, 2021-2031

7.1 Overview
7.2 Assisted Reproductive Technology
- 7.2.1 In Vitro Fertilization (IVF)
- 7.2.2 Intracytoplasmic Sperm Injection
7.3 Artificial Insemination
- 7.3.1 Intrauterine Insemination
- 7.3.2 Intracervical Insemination
- 7.3.3 Intratubal Insemination
7.4 Fertility Surgeries

8. Fertility Services Market - Revenue Analysis (USD Million) - By Patient Type, 2021-2031

8.1 Overview
8.2 Male
8.3 Female

9. Fertility Services Market - Revenue Analysis (USD Million) - By End-User, 2021-2031

9.1 Overview
9.2 Fertility Clinics
9.3 Hospitals and Surgical Clinics
9.4 Others

10. Fertility Services Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

10.1 North America
- 10.1.1 North America Fertility Services Market Overview
- 10.1.2 North America Fertility Services Market Revenue and Forecasts to 2031
- 10.1.3 North America Fertility Services Market Revenue and Forecasts and Analysis - By Procedure
- 10.1.4 North America Fertility Services Market Revenue and Forecasts and Analysis - By Patient Type
- 10.1.5 North America Fertility Services Market Revenue and Forecasts and Analysis - By End-User
- 10.1.6 North America Fertility Services Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.7.1 United States Fertility Services Market
    - 10.1.7.1.1 United States Fertility Services Market, by Procedure
    - 10.1.7.1.2 United States Fertility Services Market, by Patient Type
    - 10.1.7.1.3 United States Fertility Services Market, by End-User
  - 10.1.7.2 Canada Fertility Services Market
    - 10.1.7.2.1 Canada Fertility Services Market, by Procedure
    - 10.1.7.2.2 Canada Fertility Services Market, by Patient Type
    - 10.1.7.2.3 Canada Fertility Services Market, by Donor Type
    - 10.1.7.2.3 Canada Fertility Services Market, by End-User
  - 10.1.7.3 Mexico Fertility Services Market
    - 10.1.7.3.1 Mexico Fertility Services Market, by Procedure
    - 10.1.7.3.2 Mexico Fertility Services Market, by Patient Type
    - 10.1.7.3.3 Mexico Fertility Services Market, by End-User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East & Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East & Africa
10.5 South & Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South & Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Fertility Services Market - Key Company Profiles

13.1 CooperSurgical, Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies